Stock JULPHAR GULF PHARMACEUTICAL INDUSTRIES
Add to a list
To use this feature you must be a member
Log inSign up

News Gulf Pharmaceutical Industries

Equities

JULPHAR

AEG000201018

Delayed Abu Dhabi Securities Exchange
Other stock markets
 05:44:25 2024-04-23 am EDT 		5-day change 1st Jan Change
0.956 AED -0.42% Intraday chart for Gulf Pharmaceutical Industries -0.73% +24.58%
Mar. 21 Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting MT
Mar. 15 Abu Dhabi's Gulf Pharmaceutical Industries Resumes Trading Following FY23 Results Publication MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Gulf Pharmaceutical Industries Shares to be Suspended Ahead of Annual General Meeting
MT
Abu Dhabi's Gulf Pharmaceutical Industries Resumes Trading Following FY23 Results Publication
MT
Gulf Pharmaceutical Industries' FY23 Attributable Loss Widens; Revenue Up
MT
Gulf Pharmaceutical Industries to Halt Trading During Board Meeting
MT
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Gulf Pharmaceutical Industries P.S.C. Approves Board Appointments
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Gulf Pharmaceutical Industries P.S.C. Announces Chief Executive Officer Changes
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Gulf Pharmaceutical Industries P.S.C. Announces Resignation of Sanjay Deshmukh as Chief Operating Officer
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Cigalah Group completed the acquisition of 51% stake in Alpha Pharma L.L.C. from Gulf Pharmaceutical Industries P.S.C..
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Gulf Pharmaceutical Industries P.S.C. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Gulf Pharmaceutical Industries Announces the Resignation of Ragheb Alshakhshir as Chief Scientific Officer
CI
Quantum Genomics Société Anonyme Signs an Exclusive License and Production Agreement with Gulf Pharmaceuticals Industries Julphar
CI
Quantum Genomics Société Anonyme announced that it expects to receive $2 million in funding from Gulf Pharmaceutical Industries P.S.C.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. JULPHAR Stock
  4. News Gulf Pharmaceutical Industries